July 10 (Reuters) - Fosun International Ltd:
* STOCK EXCHANGE CONFIRMED THAT FOSUN PHARMA & FOSUN INTERNATIONAL MAY PROCEED WITH PROPOSED SPIN-OFF & SEPARATE LISTING
* EXPECTED SPIN-OFF AND SEPARATE LISTING TO INVOLVE AN OFFER FOR SUBSCRIPTION VIA AN IPO BY GLAND PHARMA OF UP TO INR12,500 MILLION
* INFORMED THAT GLAND PHARMA WILL APPLY FOR IN-PRINCIPLE APPROVAL FOR LISTING OF ITS EQUITY SHARES ON NSE & BSE
* EXPECTED THAT PROPOSED SPIN-OFF AND SEPARATE LISTING WILL ALSO INVOLVE OFFER FOR SALE OF UP TO 34.9 MILLION SHARES OF GLAND PHARMA Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.